Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun;7(2):60-67.
doi: 10.1016/j.prnil.2018.06.001. Epub 2018 Jun 14.

Report of the third Asian Prostate Cancer study meeting

Bannakij Lojanapiwat  1 , Ji Youl Lee  2 , Zhu Gang  3 , Choung-Soo Kim  4 , Ng Chi Fai  5   6   7 , Lukman Hakim  8 , Rainy Umbas  9 , Teng Aik Ong  10 , Jasmine Lim  10 , Jason L Letran  11 , Edmund Chiong  12 , Seung Hwan Lee  13 , Levent Türkeri  14 , Declan G Murphy  15 , Kim Moretti  16 , Matthew Cooperberg  17   18 , Robert Carlile  19 , Shiro Hinotsu  20 , Yoshihiko Hirao  21 , Tadaichi Kitamura  22 , Shigeo Horie  23 , Mizuki Onozawa  24 , Yasuhide Kitagawa  25 , Mikio Namiki  26 , Takashi Fukagai  27 , Jun Miyazaki  24 , Hideyuki Akaza  28   29
Affiliations

Report of the third Asian Prostate Cancer study meeting

Bannakij Lojanapiwat et al. Prostate Int. 2019 Jun.

Abstract

The Asian Prostate Cancer (A-CaP) study is an Asia-wide initiative that was launched in December 2015 in Tokyo, Japan, with the objective of surveying information about patients who have received a histopathological diagnosis of prostate cancer (PCa) and are undergoing treatment and clarifying distribution of staging, the actual status of treatment choices, and treatment outcomes. The study aims to clarify the clinical situation for PCa in Asia and use the outcomes for the purposes of international comparison. Following the first meeting in Tokyo in December 2015, the second A-CaP meeting was held in Seoul, Korea, in September 2016. This, the third A-CaP meeting, was held on October 14, 2017, in Chiang Mai, Thailand, with the participation of members and collaborators from 12 countries and regions. In the meeting, participating countries and regions presented the current status of data collection, and the A-CaP office presented a preliminary analysis of the registered cases received from each country and region. Participants discussed ongoing challenges relating to data input and collection, institutional, and legislative issues that may present barriers to data sharing, and the outlook for further patient registrations through to the end of the registration period in December 2018. In addition to A-CaP-specific discussions, a series of special lectures were also delivered on the situation for health insurance in the United States, the correlation between insurance coverage and PCa outcomes, and the outlook for robotic surgery in the Asia-Pacific region. Members also confirmed the principles of authorship in collaborative studies, with a view to publishing original articles based on A-CaP data in the future.

Keywords: Asia; Cancer; Database; Prospective study; Prostate cancer; Registry.

PubMed Disclaimer

References

    1. Akaza H., Hirao Y., Kim C.S., Oya M., Ozono S., Ye D. Asia Prostate Cancer Study (A-CaP) launch symposium. Prostate Int. 2016;4:88–96. - PMC - PubMed
    1. Kim C.S., Lee J.Y., Chung B.H., Kim W.J., Ng C.F., Hakim L. Report of the Second Asian Prostate Cancer (A-CaP) study meeting. Prostate Int. 2017;5:95–103. - PMC - PubMed
    1. Basto M., Sathanathen N., Te Marvelde L., Ryern S., Goard J., Lawrentshuk N. Patterns-of-care and health economic analysis of robot-assisted radical prostatectomy in the Australian public health system. BJU Int. 2016 Jun;117(6):930–939. - PubMed
    1. Murphy D.G., Risbridger G.P., Sandhu S. The evolving narrative of DNA repair gene defects: distinguishing indolent from lethal prostate cancer. Eur Urol. 2017 May;71(5):748–749c. - PubMed